Search results for: rn

November 21st, 2007

So… what’s with the ear horn?

Since I started blogging in June, I’ve been learning a lot about the art of conversation. While I’ve been trying to find my voice to offer perspective on stories, I’m also hearing a lot from people who either agree with or disagree with me. I often feel like I’ve just crashed a cocktail party — as I barge into some fascinating conversations that have been going on for a while without me, I sometimes find that I not only have something to add but can also leave with some useful nugget from that conversation to use elsewhere.

I’m not alone — and talking to my historian colleague Margaret, I get the impression that this really isn’t all that new. When Johnson & Johnson started back in 1886, conversations occurred all the time between the company, its customers and the community. We’ve both found that blogs can be a way for us to go back to the future to reengage with people and hear what we’ve been missing. And I’m delighted to have been joined by some of my colleagues at Johnson & Johnson in more recent postings on JNJBTW.

Alas. Though we’re trying, we still have to get better at listening.

Read More

September 25th, 2007

Sharing the Learning Curve

I have only been a part of Johnson & Johnson since the beginning of the year, and so I get questions from my friends and family all the time about what it is like now to be working at Johnson & Johnson, “the baby company.” This question is usually followed by a request for baby lotions, beauty products or Band-Aid Brand adhesive bandages.

It can be a steep learning curve coming into Johnson & Johnson and getting up to speed on its many businesses, but as I learn things I hope to share some of my observations with you. I want to provide a voice on JNJBTW that brings a bit of an “outsider’s” perspective.

Johnson & Johnson is no different than most companies in the fact it faces sizable business challenges every day. For example, as a health care company with a pharmaceuticals business, we have to deal with how to replace significant revenues from drugs that will be going off patent and how to handle unprecedented reimbursement challenges for drugs like erythropoiesis-stimulating agents (speaking of my learning curve…).

There is a healthy curiosity and a natural skepticism in the marketplace about how companies, including Johnson & Johnson, can overcome such challenges.

Read More

July 28th, 2015

What Sustains Us, We Sustain

Editor’s Note: Our Chairman and CEO, Alex Gorsky, recently shared some thoughts with our employees about why exercise is important to him and what gets him out of bed for a workout every day.  Below is his message.

By Alex Gorsky, Chief Executive Officer and Chairman of the Board of Directors of Johnson & Johnson

In a recent New York Times Well blog post, health columnist Jane Brody talks about her personal motivation for getting in daily workouts. You might be surprised to hear she isn’t driven by weight loss or even overall health goals. Jane focuses on the immediate benefits of exercise – like greater energy, a clear head and an overall preparedness for the day’s tasks.

According to the article, people who focus on the long-term, ironically, spend the least amount of time exercising. Studies show that the instant effects of exercise, such as increased energy, are better motivators than long-term goals like physical fitness, health and weight loss.

I couldn’t agree more with Jane’s approach and this philosophy. I start each morning at 5:00 A.M. with an hour workout of both cardio and weight training. Even on my busiest days I never skip a workout because it makes me feel energized and ready for the day ahead.

Read More

July 28th, 2015

J&J Launches the Consumer Experience Center

By Josh Ghaim, Ph.D., Chief Technology Officer, Johnson & Johnson Family of Consumer Companies

Consumer Experience Center

I often remind my team to keep our consumer purpose at the center of everything that we do. To me, our purpose centers on caring for people around the world by anticipating their needs, creating solutions and experiences that help them and those they care for live healthy, vibrant lives.

Today’s launch of the Johnson & Johnson Consumer Experience Center is all about that consumer purpose. The center is a state-of-the art research & development (R&D) hub focused on gaining holistic insights about the millions of consumers we serve every day.

Our R&D teams get to interact with our volunteer consumers in ‘labs’ designed to replicate how people live and use our baby, over-the-counter (OTC), beauty and oral care products. The center’s testing rooms allow us to simulate real-life consumer interactions with our products, including the shower, the tub and the vanity sink within a bathroom, a dental lab and a hair and color cosmetics station.

Many people on our team have been working diligently to bring the vision of an on-site consumer laboratory to life. With the realization of this hard work and the opening of this state-of-the-art center, our internal research teams will now work more cohesively to engage each other and the consumer for brainstorming, as well as observations in home-like settings.

Read More

July 20th, 2015

We can and We Must #MakeHIVstory

By Brian Woodfall, M.D., Head of Development and Global Medical Affairs, Infectious Diseases and Vaccines at the Janssen Pharmaceutical Companies of Johnson & Johnson

As I arrived at the International AIDS Society conference this weekend, my mind wandered to the last time the IAS conference was in Vancouver in 1996.

Back then, HIV was still a mysterious and invariably fatal disease. It was also a divisive one, with patients frequently marginalized and the event itself scathingly labelled an “AIDS Circus Comes to Town” by some in the Canadian media.

Yet that 1996 conference provided a watershed moment: the arrival of highly active antiretroviral therapy (HAART). This ground-breaking method of combination therapy literally changed HIV treatment overnight and meant patients with months to live suddenly faced the prospect of surviving for many years.

Fast forward to today and our world is very different. There is still much to do, particularly in places like Africa, Eastern Europe and Latin America, but in many cases, new and improved therapies have turned HIV from a death sentence to a chronic, treatable condition. As people with HIV increasingly enjoy normal lifespans, at Janssen we continue to seek out and collaborate with the best scientists to develop potentially even better, more convenient treatments.

Read More

July 9th, 2015

Relentless. Forward. Motion.

Editor’s Note: Starting on July 14, ultra-endurance brothers Scott and Rhys Jenkins from Wales, United Kingdom, hope to set the World Record for the ‘Fastest Double Crossing of Death Valley on Foot’ by attempting to run 10 marathons in four days. The pair is also hoping to raise £10,000 or $14,000 for Save the Children and Operation Smile – two signature partners of Johnson & Johnson. In addition to raising funds on their own, the brothers are supporting the charities by raising funds through the Johnson & Johnson Donate a Photo app and the Charity Miles app. Scott, who works for our DePuy Synthes business, shares his trepidation about the almost impossible race terrain and his motivation to help children around the world.


By Scott Jenkins, Sales Consultant for DePuy Synthes in Great Britain

On Tuesday (July 14), my younger (and in his humble opinion, better looking) brother and I will be attempting to run a double crossing of Death Valley in California, trying to set a new world record in the process. Rhys and I have aptly named this challenge the Death Valley Double. To date, only eight individuals have attempted such a feat and only three have managed to complete it.

Read More

July 7th, 2015

Using Technology to Take The Guesswork Out of Upper Respiratory Symptoms

By Sumeet Narula,  Digital Brand Manager, McNeil Consumer Healthcare


Many of us tap into the knowledge of our communities for restaurant recommendations, parenting advice, checking the weather, and staying on top of the most talked-about stories of the day. But what if we could also utilize our communities to stay better informed about our health?

That’s what our team at McNeil Consumer Healthcare asked as we considered how to better serve people who suffer from upper respiratory illnesses – symptoms such as cough, runny nose, or itchy eyes. We know is that it’s confusing for people to determine the source of their symptoms — allergies, a cold or the flu – which is crucial for determining the best treatment option. We also know that there are various triggers for respiratory symptoms, including pollen, viruses, and weather changes.

Clearing up this confusion and helping people track the environmental factors that aggravate upper respiratory illness was the inspiration for our new HEALTHYDAY App. Using a patent-pending algorithm, HEALTHYDAY aggregates anonymous health data from the same trusted sources that doctors and hospitals use. It combines this data with anonymous social mentions of illnesses or symptoms in real time to help users see if other people in their community are suffering from upper respiratory illness – and what is causing their symptoms.

Read More

June 24th, 2015

Sports Injury Prevention Programs Help Keep Kids Moving

With the school year coming to an end, more of our days are spent out on the soccer field or in right field. Unfortunately, with an increase in sports activity parents worry more about their children’s risk of sports injury. More than 2.6 million children and adolescents are treated in the emergency department each year for sports and recreation-related injuries.[1] In fact, children aged 15-17 experience the highest emergency room visits for sports injuries, many of which are preventable.[2] These injuries are not limited to contact sports; in fact as many as 70 percent of anterior cruciate ligament (ACL) knee injuries involve little or no contact with the other player.[3]

DS SafeKids

DePuy Synthes Mitek Sports Medicine has worked with sports medicine orthopedic practices and Safe Kids Worldwide™ for nearly a decade to host educational clinics throughout the country to keep kids moving. This program, called PASSION2PLAY™, educates parents, coaches and young athletes about the importance of preventing sports-related injuries through sponsored educational clinics featuring clinical experts as well as tips for proper warm-up routines, injury prevention strategies and when it might be necessary to seek appropriate medical attention for injuries.

The latest PASSION2PLAY event with Safe Kids Worldwide featured professional football player Rueben Randle, who joined local teens in Waldwick, New Jersey and shared his experience with sports injury in the NFL and the importance of stretching and warming up.

Read More

June 16th, 2015

Cancer and Clots: An Unrecognized and Under-Researched Patient Burden

By Paul Burton, MD, PhD, Vice President, Medical Affairs, Janssen

More than one-third of all men and women in the United States will be diagnosed with cancer over the course of their lives. Living with cancer, the treatments and their side effects are significant burdens on their own. What many people with cancer often don’t realize is they are up to five times more likely to develop life-threatening blood clots than people the same age without cancer. These clots can occur deep in the veins in many parts of the body and sometimes travel to the lungs, a condition called venous thromboembolism (VTE). This risk is even more pronounced when patients with cancer undergo chemotherapy.

Blood clots are the second-leading cause of death in patients with cancer. We need a better understanding of how we can treat and prevent them, particularly for a large number of the one million patients who are treating their cancer outside the hospital.

That’s why the Janssen Pharmaceutical Companies of Johnson & Johnson, in conjunction with Bayer HealthCare, are furthering our commitment to addressing the most important unmet medical needs of our time by initiating a new research program: CALLISTO. CALLISTO is aimed at generating new evidence in the prevention and treatment of blood clots in patients with a wide range of cancer types.

Read More

June 5th, 2015

Domestic Violence: A Human Health Crisis

By Dr. Husseini Manji, Global Head, Neuroscience, Janssen Research & Development and Dr. Danielle Coppola, Senior Director, Compound Development Team, and Clinical Leader, Janssen Research & Development

Domestic Violence: A Human Health Crisis

When we talk about a public health care crisis, conversations often turn to serious illnesses like diabetes, cancer, and cardiovascular disease. But the growing body of evidence shows that domestic violence can be as devastating as the world’s most complex diseases.

The Centers for Disease Control and Prevention (CDC) lists domestic violence— sometimes referred to as “intimate partner violence” or IPV—as a “serious, preventable public health problem.” Domestic violence affects individuals and families and places a heavy burden on communities, law enforcement, and health care systems. In the United States alone:

  • Twenty-four people per minute are victims of physical violence by an intimate partner.1 In one study, 53 percent of men and 69 percent of women said they had experienced some form of intimate partner violence before the age of 25.2
  • Women ages 16 to 24 are four times more likely than the general population to be victims of partner violence.3
  • Up to 70 percent of men who abuse their partners also sexually or physically abuse their children.4
  • Medical costs associated with intimate partner violence are estimated at $5.8 billion each year.

Read More